PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Apr-2023 BioDuro-Sundia Wins Life Sciences Review Top 10 BPO Award Businesswire
04-Apr-2023 Crane Company Completes Separation from Crane Holdings, Co. Businesswire
04-Apr-2023 FDA Grants Accelerated Approval for PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer Businesswire
04-Apr-2023 FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination With Padcev® (enfortumab vedotin-ejfv) for First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer Businesswire
03-Apr-2023 Enveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results Businesswire
03-Apr-2023 Legend Biotech Establishes Strategic Advisory Board Businesswire
03-Apr-2023 Precision Biologics Announces Publication Of First-In-Human Phase 1 Clinical Trial With NEO-201 Businesswire
03-Apr-2023 Architect Equity Announces Sale of Solution Net Systems to Alstef Group Businesswire
03-Apr-2023 Fytexia et Plant Advanced Technologies PAT annoncent la signature d’une collaboration stratégique en nutrition autour du programme N’GINS Businesswire
03-Apr-2023 Aelis Farma Reports Its 2022 Annual Financial Results and Confirms Its 2023 Outlook Businesswire
03-Apr-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lincoln National Corporation (LNC) on Behalf of Investors Businesswire
03-Apr-2023 Sumitomo Pharma Subsidiary Companies in the U.S., Including Sunovion, to Combine and Form Sumitomo Pharma America Businesswire
03-Apr-2023 PharmaJet Partner Gennova Biopharmaceuticals Seeks Emergency Use Authorization in India for the First Needle-Free mRNA Vaccine Omicron Booster Businesswire
03-Apr-2023 Napoli Shkolnik Congratulates Partner Harold P. Naughton Jr., on his Judicial Appointment to the U.S. District Court for the District of Massachusetts Businesswire
03-Apr-2023 Alzamend Neuro Announces the Initiation of a Phase I/IIA Trial for Its Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer’s Type Businesswire
03-Apr-2023 Zymeworks Announces Participation in Upcoming Investor Conferences Businesswire
03-Apr-2023 Aviceda Announces 3 Presentations about AVD-104, its Lead Glyco-mimetic Nanoparticle, As a Novel Treatment for Geographic Atrophy from Macular Degeneration, at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, April 2023 Businesswire
03-Apr-2023 Bev Gregory Joins Alliant Insurance Services’ San Diego Employee Benefits Team Businesswire
03-Apr-2023 AnHeart Therapeutics Appoints Edward Lang Jr. as Chief Business Officer Businesswire
03-Apr-2023 Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia Businesswire